Youssef Bessada

Assistant Clinical Professor

University of Connecticut

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Youssef Bessada is an Assistant Clinical Professor at the University of Connecticut, USA. His research primarily focuses on cardiovascular health, specifically pharmacotherapy in peripheral artery disease and atrial fibrillation. Recent publications include studies on the safety and efficacy of various antithrombotic strategies and the optimization of lipid treatment in a clinical setting.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (2)

Craig I. Coleman

UNITED STATES

View details

C. Michael White

Professor

University of Connecticut

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Youssef Bessada

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

The Impact of a Pharmacist‐Driven, Interprofessional Lipid Optimization Workflow in a Transitions of Care (LOW‐TOC) Pilot Program

Sodium-glucose transporter-2 inhibitors: safety and efficacy in patients with peripheral artery disease

A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome

Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis

Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.

Leveraging the Cardiovascular Team in Peripheral Artery Disease Diagnosis: A Call to Action

Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies

Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea.

Collaborators (2)

Craig I. Coleman

C. Michael White

Make your next move.